Vivos (RDGL) Payables (2010 - 2025)

Vivos (RDGL) reported Payables of $92472.0 for Q4 2025, up 7.26% on a YoY basis from $86209.0 in Q4 2024, and down 17.94% sequentially from $112693.0 in Q3 2025.

Vivos (RDGL) Payables (2010 - 2025) Analysis & Trends

Vivos (RDGL) has 16 years of Payables data on file, last reported at $92472.0 in Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 7.26% year-over-year to $92472.0; the trailing twelve-month figure through Dec 2025 stood at $92472.0 (up 7.26% YoY), and the FY2025 full-year result was $92472.0, up 7.26% from the prior year.
  • Payables declined to $92472.0 in Q4 2025, from $112693.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $443345.0 in Q1 2021 to a low of $48820.0 in Q3 2024.
  • A 5-year average of $145891.5 and a median of $112751.5 in 2023 frame the typical range for Payables.
  • Across the five-year window, Payables soared 2855.63% in 2021 and sank 80.71% in 2022, its largest moves.
  • Tracing RDGL's Payables over 5 years: stood at $166915.0 in 2021, then plunged by 51.06% to $81692.0 in 2022, then surged by 199.91% to $245004.0 in 2023, then tumbled by 64.81% to $86209.0 in 2024, then grew by 7.26% to $92472.0 in 2025.
  • Business Quant data shows RDGL's Payables at $92472.0 in Q4 2025, $112693.0 in Q3 2025, and $96458.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 5.78 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 1.93 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 2.64 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 181.10 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 3.42 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 1.18 Bn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 2.39 Bn
10 Vivos 27.16 Mn 25.60 Mn -3,105.00 92,472.00

Historic Data

Download Data
DateValue
Dec 31, 2025 92,472.00
Sep 30, 2025 112,693.00
Jun 30, 2025 96,458.00
Mar 31, 2025 115,378.00
Dec 31, 2024 86,209.00
Sep 30, 2024 48,820.00
Jun 30, 2024 166,560.00
Mar 31, 2024 74,766.00
Dec 31, 2023 245,004.00
Sep 30, 2023 107,369.00
Jun 30, 2023 112,810.00
Mar 31, 2023 48,989.00
Dec 31, 2022 81,692.00
Sep 30, 2022 160,953.00
Jun 30, 2022 215,093.00
Mar 31, 2022 85,515.00
Dec 31, 2021 166,915.00
Sep 30, 2021 231,413.00
Jun 30, 2021 225,376.00
Mar 31, 2021 443,345.00